Loading
Regional Health Properties, Inc Stock: price and insider trades · United States
1 insider bought €16k of shares over the last 90 days, the latest by Radoff Bradley Louis, filed 04 Aug 2026.
Regional Health Properties, Inc: what insiders have been doing
Regional Health Properties, Inc belongs to the Healthcare & Pharma sector. Filings by its managers are published through SEC (Form 4). The last twelve months, up to 22 October 2026, brought 13 filings signed by 2 insiders.
Both sides are active: 10 purchases worth €30k and 2 sales worth €5,043, from 2 insiders and 1 insider respectively. Netting one side against the other leaves €25k of net buying. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Those buying include 1 major shareholder and 1 chief executive. Biggest ticket of the year: €6,903, bought by Radoff Bradley Louis and made public on 4 August 2026.
The most recent open-market purchase was published on 4 August 2026, 81 days ago.
With 13 filings in twelve months, the company is more active than the median of 8 filings across the 277 companies we follow on the same exchange. Over the whole record (from 2016), the tally stands at 56 purchases and 9 sales. In its latest annual report filed with the SEC (10-K, fiscal year ended 31 December 2025), the company reported revenue of 53.2 m USD and net income of 3.4 m USD.
For comparison within the same sector, see the insider buying recorded at Xenon Pharmaceuticals Inc. and Vivos Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
116
Thresholds
n/a
Buy Volume
€594,849
56 ops. · all time
Sell Volume
€161,458
9 ops. · all time
Who traded when
BuySaleBradley Louis Radoff7 buys2 sales
Brent Morrison3 buys
Paul Jason O'sullivan3 buys
Gene E. Burleson1 buy
Since the insiders bought
- -25.0%Entry US$0.20 · Close 19 Oct 2026 US$0.15
- -51.6%Entry US$0.31 · Close 19 Oct 2026 US$0.15
- -33.8%Entry US$0.30 · Close at T+365 US$0.20
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
US$0.15
Analyst consensus
Income statement
RevenueUS$53.2M
Gross profitUS$14.6M27% margin
EBITDAUS$8.1M15% margin
Net incomeUS$3.4M5.0% margin
Valuation
Beta0.73
Balance sheet & cash
Total debtUS$42.5M
Free Cash Flow-US$3.1M
Debt / Equity1434%
Profitability & ownership
ROA-0.6%
% institutions0.0%
Last declaration on 4 August 2026
Declarations116 total
6,300 shares@ US$1.289632.3% of flowCommon StockSEC:0000921895-26-001950:0
Canonical exit: 12 Jul 2026 (T+90)
3,511 shares@ US$1.296918.1% of flowCommon StockSEC:0000921895-26-001950:1
Canonical exit: 13 Jul 2026 (T+90)
2,000 shares@ US$1.4311.4% of flowCommon StockSEC:0000921895-26-001950:2
Canonical exit: 21 Jul 2026 (T+90)
100 shares@ US$1.210.5% of flowCommon StockSEC:0000921895-26-001950:3
Canonical exit: 12 Jul 2026 (T+90)
500 shares@ US$1.402.8% of flowCommon StockSEC:0000921895-26-001950:4
Canonical exit: 21 Jul 2026 (T+90)
1,000 shares@ US$1.405.6% of flowCommon StockSEC:0000921895-26-001950:5
Canonical exit: 26 Jul 2026 (T+90)
1,009 shares@ US$1.42415.8% of flowCommon StockSEC:0000921895-26-001950:6
Canonical exit: 28 Jul 2026 (T+90)
100 shares@ US$1.060.4% of flowCommon StockSEC:0000921895-26-001950:8
5,000 shares@ US$1.1523.2% of flowCommon StockSEC:0000921895-26-001950:7
100,000 shares0Common StockSEC:0001493152-26-005039:0
1,950 shares@ US$1.451.6% of flowCommon StockSEC:0001493152-25-027286:1
Canonical exit: 11 Mar 2026 (T+90)
4,099 shares@ US$1.455.1% of flowCommon StockSEC:0001493152-25-027286:0
Canonical exit: 9 Mar 2026 (T+90)
5,403 shares@ US$1.416.5% of flowCommon StockSEC:0001493152-25-026796:0
Canonical exit: 4 Mar 2026 (T+90)
5,000 shares@ US$1.99100.0% of flowCommon StockSEC:0001641172-25-026402:0
Canonical exit: 27 Nov 2025 (T+90)
5,600 shares@ US$1.9222.6% of flowCommon StockSEC:0001641172-25-025228:1
Canonical exit: 17 Nov 2025 (T+90)
3,800 shares@ US$1.8014.4% of flowCommon StockSEC:0001641172-25-025228:2
Canonical exit: 18 Nov 2025 (T+90)
10,600 shares@ US$1.8572.1% of flowCommon StockSEC:0001641172-25-025228:0
Canonical exit: 16 Nov 2025 (T+90)
22 sharesCommon StockSEC:0001641172-25-025113:1
13,606 sharesCommon StockSEC:0001641172-25-025113:2
2,871 sharesSeries D 8% Cumulative Conver. Redeemable Preferred SharesSEC:0001641172-25-025113:3
20 sharesSeries D 8% Cumulative Conver. Redeemable Preferred SharesSEC:0001641172-25-025113:4
12,009 sharesSeries D 8% Cumulative Conver. Redeemable Preferred SharesSEC:0001641172-25-025113:5
3,253 sharesCommon StockSEC:0001641172-25-025113:0
125,663 sharesCommon StockSEC:0001641172-25-024709:1
1,133 sharesCommon StockSEC:0001641172-25-024709:2
25 of 116 declarations
About Regional Health Properties, Inc
Regional Health Properties, Inc. is a U.S.-listed healthcare real estate company trading on the NYSE American under the RHEP/RHEPA share-class references appearing in company materials and SEC filings. Founded in 1991 and headquartered in Atlanta, Georgia, United States, the company traces its roots to AdCare Health Systems, Inc. and has steadily shifted its business model since 2014 from owning and operating skilled nursing facilities to becoming a more focused healthcare property investment platform. Today, its business is centered on owning, operating, and leasing real estate used for long-term care, senior housing, and, more recently, certain pharmacy-related services.
From an equity analyst’s perspective, Regional Health Properties occupies a niche position within the healthcare real estate segment. Rather than being a large diversified REIT, it is a smaller, specialized platform with exposure to long-term care assets and operating arrangements. Its portfolio includes skilled nursing facilities and multi-service campuses across several U.S. states. In its latest annual report, the company disclosed approximately $52.8 million of investments in eleven healthcare real estate facilities at year-end 2024, spread across five states. That geographic footprint is relatively compact, but it is consistent with a specialty operator focused on select healthcare assets rather than broad national scale.
Read moreShow less
The company’s revenue model is somewhat hybrid. It can generate rental income from leased properties, while at certain points it also derives income from patient care operations and management-related activities. This creates a mix that sits between a traditional healthcare landlord and an operating company, offering flexibility but also introducing more execution complexity than a pure-play property owner. Competitive positioning therefore depends heavily on tenant quality, occupancy trends, reimbursement dynamics in long-term care, and the ability to manage regulatory and operational risk in a highly specialized segment.
Recent company developments have continued to reflect this strategic emphasis. The 2024 annual report showed higher total revenue, driven mainly by patient care revenues, while management fee income was no longer present in the period. That suggests ongoing portfolio and business-mix adjustment rather than a static asset base. The company also maintains an investor relations presence and files regularly with the SEC, including Form 4 insider transaction disclosures that can be important for investors monitoring management sentiment.
For French, Belgian, and Swiss investors, Regional Health Properties is best viewed as a small-cap U.S. healthcare real estate name listed on the NYSE American market in the United States, with a specialized asset base, modest scale, and a risk profile that is more idiosyncratic and event-driven than that of larger healthcare REIT peers.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
